Reinsurers must adapt strategies to align with risk introduced by GLP-1 therapies: Gallagher Re
Reinsurance News - Mar 28, 2025
Gallagher Re, a reinsurance brokerage and risk management services provider, has released a report on the impact of GLP-1 receptor agonists on medical trends and reinsurance. According to the report, as these therapies continue to reshape medical trends and insurance structures, reinsurance provider...
Recommended Articles
Posted: Apr 02, 2026
US cyber reinsurance rates fell around 32% during the April 1 renewals, impacted by a surge in exces...
Posted: Apr 02, 2026
Aon’s Reinsurance Solutions, the reinsurance division of global broker Aon, has appointed Jukgrid Tr...
Posted: Apr 02, 2026
Markel, the insurance operations within Markel Group Inc., has announced the appointment of James Sh...